Neurocrine Biosciences reported $285.7M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 117.68M 1.92M
Acorda Therapeutics ACOR:US $ 41.12M 4.88M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
ALKERMES ALKS:US $ 438.52M 23.84M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Aptinyx Inc APTX:US $ 5.68M 945K
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Cytokinetics CYTK:US $ 66.84M 0M
Dynavax Technologies DVAX:US $ 345.2M 121M
Enanta Pharmaceuticals ENTA:US $ 23.04M 7.7M
Exelixis EXEL:US $ 304.52M 15.44M
Gilead Sciences GILD:US $ 9220M 662M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
Intra Cellular Therapies ITCI:US $ 70.63M 11.56M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Prothena PRTA:US 40.11M 3.61M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Repligen RGEN:US $ 423.52M 0.81M
Rigel Pharmaceuticals RIGL:US $ 54.96M 4.27M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Teva Pharmaceutical TEVA:IT 11B 617M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
Xoma XOMA:US $ 8.42M 534K
YTE INCY:US $ 926.67M 40.51M